A groundbreaking blood test, Galleri, capable of detecting multiple cancer types in one screening, is under FDA review and could receive approval by the end of this year.

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

A groundbreaking blood test, Galleri, capable of detecting multiple cancer types in one screening, is under FDA review and could receive approval by the end of this year.